Acoustic Stimulation During Restricted Sleep After Sleep Deprivation

April 22, 2024 updated by: JOHN D. HUGHES, Walter Reed Army Institute of Research (WRAIR)

Slow-wave Sleep Enhancement Using Acoustic Stimulation to Facilitate Performance Recovery During Restricted Sleep After Sleep Deprivation

The purpose of this study is to determine if brief sounds or tones presented within a restricted period of recovery sleep after a period of sleep deprivation will enhance restorative properties and improve performance during a subsequent period of wakefulness.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

44

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 39 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy men and non-pregnant, non-lactating women 18 to 39 years of age (inclusive)
  • Must demonstrate adequate comprehension of the protocol, by achieving a score of at least 80% correct on a short multiple-choice quiz. Individuals who fail to achieve a passing score on the initial quiz will be given one opportunity to retest after a review of protocol information. Individuals who fail the comprehension assessment for the second time will be disqualified.

Exclusion Criteria:

  • You must have learned English as your first language
  • You must have a body mass index (BMI) below 30 (this is a mathematical calculation of your height and weight)
  • You must not have current or a history of sleeping problems (for example, insomnia or sleep apnea), or symptoms that indicate a potential sleep disorder
  • You must get an average of 6-9 hours of sleep per night and maintain a normal sleep/wake schedule
  • You must not drink excessive amounts of caffeine, alcohol, or smoke cigarettes regularly
  • You must not be on certain medications (determined on a case by case basis)
  • You must test negative for illicit drugs
  • Women must not be pregnant or nursing
  • You must not be participating in another ongoing clinical trial
  • You must have a social security number or tax identification number in order to be paid for screening and participation in the study
  • You cannot have a history of the following conditions: Cardiovascular disease, a neurologic disorder, pulmonary disease requiring inhaler use, kidney disease or kidney abnormalities, liver disease of liver abnormalities, a history of psychiatric disorder requiring hospitalization or medication within the last two years or for a continuous period of more than 6 months in the last ten years

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Subjects Who Received Acoustic Stimulation
Following 40 hours of deprivation participants will sleep for approximately a four hour recovery sleep period and receive acoustic stimulation via the Philips SmartSleep during slow-wave sleep. They will then sleep for second night of four hour recovery sleep and receive acoustic stimulation via the Philips Smart Sleep device during slow-wave sleep again.
Prior to bedtime on the first two recovery nights, a Philips SmartSleep device will be applied to the head of each subject. Subjects will receive acoustic stimulation during the four hours of sleep.
Sham Comparator: Subjects Who Received Sham (no Acoustic Stimulation)
Following 40 hours of deprivation participants will sleep for approximately a four hour recovery sleep period and receive Sham (no acoustic stimulation) via the Philips SmartSleep during slow-wave sleep. They will then sleep for second night of four hour recovery sleep and receive Sham (no acoustic stimulation) via the Philips Smart Sleep device during slow-wave sleep again.
Prior to bedtime on the first two recovery nights, a Philips SmartSleep device will be applied to the head of each subject. Subjects will receive Sham (no acoustic stimulation) during the four hours of sleep.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measure the effects of sleep deprivation/sleep restriction on performance using the Psychomotor Vigilance Task (PVT)
Time Frame: 8 days
Performed at approximately 75 minutes intervals throughout the sleep deprivation and recovery days
8 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measure simple arithmetic processing using the Mathematical Processing Subtest of the Automated Neuropsychological Assessment Metrics 4 (ANAM4)
Time Frame: 5 days
Computer based series of mathematical calculations
5 days
Measure current mood states using the Mood Analogue Scale (MAS)
Time Frame: 5 days
Computer based self adjective checklist of measure mood states
5 days
Measure latency to sleep using the Maintenance of Wakefulness Test (MWT)
Time Frame: 5 days
Subjects will be escorted to their individual darkened, sound-attenuated bedrooms and allowed to lie down on their beds. They will be instructed to close their eyes and try to remain awake. Polysomnography will be monitored online.
5 days
Measure alertness using the Karolinska Sleepiness Scale (KSS)
Time Frame: 5 days
Computer based self rated level of sleepiness
5 days
Measure various aspects of mood using the Walter Reed Army Institute of Research (WRAIR) Mood Battery
Time Frame: 5 days
Computer based battery testing various aspects of mood
5 days
Measure various aspects of Sleep and Wakefulness using Polysomnographic measurements with video
Time Frame: 5 days
Sleep will be measured during the night using polysomnography
5 days
Measure various aspects of Sleep and Wakefulness using Actigraphy
Time Frame: 22 days
A watch-like device called an actigraph will measure movement to determine wake and sleep
22 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 14, 2022

Primary Completion (Estimated)

October 1, 2025

Study Completion (Estimated)

October 1, 2026

Study Registration Dates

First Submitted

February 17, 2022

First Submitted That Met QC Criteria

March 23, 2022

First Posted (Actual)

April 4, 2022

Study Record Updates

Last Update Posted (Estimated)

April 23, 2024

Last Update Submitted That Met QC Criteria

April 22, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Performance

Clinical Trials on Philips SmartSleep Acoustic Stimulation Device

3
Subscribe